Novan reports fourth cohort data from phase II trial of SB-206 for molluscum contagiosum Dec. 12, 2018
Phase II study of serlopitant demonstrates reduction of pruritus associated with psoriasis Dec. 11, 2018
Leo Pharma initiates phase IIb studies of delgocitinib for atopic dermatitis and chronic hand eczema Dec. 3, 2018
Positive phase II data presented, initiation of phase III pemphigus program announced for PRN-1008 Nov. 30, 2018
Leo Pharma and PellePharm collaborate to advance innovative therapies for rare skin diseases Nov. 22, 2018
Tremfya receives additional indication approval as first biologic agent for palmoplantar pustulosis Nov. 21, 2018
RSS